179 related articles for article (PubMed ID: 10542264)
1. Smad7 differentially regulates transforming growth factor beta-mediated signaling pathways.
Zhu HJ; Iaria J; Sizeland AM
J Biol Chem; 1999 Nov; 274(45):32258-64. PubMed ID: 10542264
[TBL] [Abstract][Full Text] [Related]
2. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.
Ebisawa T; Fukuchi M; Murakami G; Chiba T; Tanaka K; Imamura T; Miyazono K
J Biol Chem; 2001 Apr; 276(16):12477-80. PubMed ID: 11278251
[TBL] [Abstract][Full Text] [Related]
3. Ultraviolet irradiation blocks cellular responses to transforming growth factor-beta by down-regulating its type-II receptor and inducing Smad7.
Quan T; He T; Voorhees JJ; Fisher GJ
J Biol Chem; 2001 Jul; 276(28):26349-56. PubMed ID: 11320083
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
[TBL] [Abstract][Full Text] [Related]
6. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
Monteleone G; Kumberova A; Croft NM; McKenzie C; Steer HW; MacDonald TT
J Clin Invest; 2001 Aug; 108(4):601-9. PubMed ID: 11518734
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta1 induces nuclear export of inhibitory Smad7.
Itóh S; Landström M; Hermansson A; Itoh F; Heldin CH; Heldin NE; ten Dijke P
J Biol Chem; 1998 Oct; 273(44):29195-201. PubMed ID: 9786930
[TBL] [Abstract][Full Text] [Related]
8. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB
Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201
[TBL] [Abstract][Full Text] [Related]
9. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
10. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
[TBL] [Abstract][Full Text] [Related]
11. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling.
Ferrigno O; Lallemand F; Verrecchia F; L'Hoste S; Camonis J; Atfi A; Mauviel A
Oncogene; 2002 Jul; 21(32):4879-84. PubMed ID: 12118366
[TBL] [Abstract][Full Text] [Related]
12. Heteromeric and homomeric transforming growth factor-beta receptors show distinct signaling and endocytic responses in epithelial cells.
Doré JJ; Edens M; Garamszegi N; Leof EB
J Biol Chem; 1998 Nov; 273(48):31770-7. PubMed ID: 9822641
[TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
14. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses.
Itoh S; Thorikay M; Kowanetz M; Moustakas A; Itoh F; Heldin CH; ten Dijke P
J Biol Chem; 2003 Feb; 278(6):3751-61. PubMed ID: 12446693
[TBL] [Abstract][Full Text] [Related]
15. Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer.
Wagner M; Kleeff J; Lopez ME; Bockman I; Massaqué J; Korc M
Int J Cancer; 1998 Oct; 78(2):255-60. PubMed ID: 9754660
[TBL] [Abstract][Full Text] [Related]
16. Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers.
Stockwell BR; Schreiber SL
Curr Biol; 1998 Jun; 8(13):761-70. PubMed ID: 9651680
[TBL] [Abstract][Full Text] [Related]
17. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.
Liu X; Nagarajan RP; Vale W; Chen Y
FEBS Lett; 2002 May; 519(1-3):93-8. PubMed ID: 12023024
[TBL] [Abstract][Full Text] [Related]
19. Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation.
Li JH; Zhu HJ; Huang XR; Lai KN; Johnson RJ; Lan HY
J Am Soc Nephrol; 2002 Jun; 13(6):1464-72. PubMed ID: 12039975
[TBL] [Abstract][Full Text] [Related]
20. Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells.
Bilezikjian LM; Corrigan AZ; Blount AL; Chen Y; Vale WW
Endocrinology; 2001 Mar; 142(3):1065-72. PubMed ID: 11181520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
